09/03/2026
and are both making headlines in the weight-loss conversation—but they work differently and are at very different stages of availability.
Our latest Retatrutide vs Semaglutide comparison breaks down what you should know:
💜 Semaglutide: Targets the GLP-1 receptor and is available in FDA-approved medications for weight management
🧬 Retatrutide: Targets GIP, GLP-1, and glucagon receptors
📉 Retatrutide has demonstrated significant weight reduction in Phase 3 clinical trials
🔬 Retatrutide remains investigational and is not currently FDA approved
⚖️ The right weight-management approach depends on individual health needs and medical guidance
Learn how these two medications compare and what the research currently shows.
Read the full blog: https://wix.to/k3XvznF